Telzap® Plus (Telsar® Rlus)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceHydrochlorothiazide + TelmisartanHydrochlorothiazide + Telmisartan
Similar drugsTo uncover
  • MykardisPlus®
    pills inwards 
    Boehringer Ingelheim International GmbH     Germany
  • MykardisPlus®
    pills inwards 
    Boehringer Ingelheim International GmbH     Germany
  • Telzap® Plus
    pills inwards 
    Zentiva c.s.     Czech Republic
  • Telpres Plus
    pills inwards 
    SiNViTi Pharma Co., Ltd.     Cyprus
  • Telsartan® H
    pills inwards 
    Dr. Reddy's Laboratories Ltd.     India
    • Dosage form: & nbsppills
    ATX: & nbsp

    C.09.D.A.07   Telmisartan in combination with diuretics

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004359
    Date of registration:30.06.2017
    Expiration Date:30.06.2022
    The owner of the registration certificate:Zentiva c.s.Zentiva c.s. Czech Republic
    Manufacturer: & nbsp
    Illustrated instructions
      Instructions
      Up
      talkdrugs

      +8 (800)555-35-35

      [email protected]

      The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

      The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

      It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

      All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.